Lokki ML - Search Results

1

Osteoid Metaplasia in Femoral Artery Plaques Is Associated With the Clinical Severity of Lower Extremity Artery Disease in Men.

Laivuori M, Tolva J, Lokki AI, Linder N, Lundin J, Paakkanen R, Albäck A, Venermo M, Mäyränpää MI, Lokki ML, Sinisalo J. Laivuori M, et al. Among authors: lokki ml. Front Cardiovasc Med. 2020 Dec 10;7:594192. doi: 10.3389/fcvm.2020.594192. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33363220 Free PMC article.

2

Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.

Saksi J, Ijäs P, Mäyränpää MI, Nuotio K, Isoviita PM, Tuimala J, Lehtonen-Smeds E, Kaste M, Jula A, Sinisalo J, Nieminen MS, Lokki ML, Perola M, Havulinna AS, Salomaa V, Kettunen J, Jauhiainen M, Kovanen PT, Lindsberg PJ. Saksi J, et al. Among authors: lokki ml. Circ Cardiovasc Genet. 2014 Oct;7(5):588-98. doi: 10.1161/CIRCGENETICS.113.000499. Epub 2014 Aug 13. Circ Cardiovasc Genet. 2014. PMID: 25122052

3

Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome.

Tolva J, Paakkanen R, Jarva H, Pussinen P, Havulinna AS, Salomaa V, Sinisalo J, Lokki ML. Tolva J, et al. Among authors: lokki ml. Atherosclerosis. 2017 Nov;266:58-63. doi: 10.1016/j.atherosclerosis.2017.09.023. Epub 2017 Sep 21. Atherosclerosis. 2017. PMID: 28982023

4

The complexity and diversity of major histocompatibility complex challenge disease association studies.

Lokki ML, Paakkanen R. Lokki ML, et al. HLA. 2019 Jan;93(1):3-15. doi: 10.1111/tan.13429. Epub 2018 Dec 20. HLA. 2019. PMID: 30468004 Review.

5

Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis.

Lahtela E, Kankainen M, Sinisalo J, Selroos O, Lokki ML. Lahtela E, et al. Among authors: lokki ml. Front Immunol. 2019 Dec 24;10:2964. doi: 10.3389/fimmu.2019.02964. eCollection 2019. Front Immunol. 2019. PMID: 31921204 Free PMC article.

6

Complement activation and regulation in preeclamptic placenta.

Lokki AI, Heikkinen-Eloranta J, Jarva H, Saisto T, Lokki ML, Laivuori H, Meri S. Lokki AI, et al. Among authors: lokki ml. Front Immunol. 2014 Jul 9;5:312. doi: 10.3389/fimmu.2014.00312. eCollection 2014. Front Immunol. 2014. PMID: 25071773 Free PMC article.

7

Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies.

Paakkanen R, Palikhe A, Seppänen M, Nieminen MS, Vauhkonen H, Saikku P, Lokki ML, Sinisalo J. Paakkanen R, et al. Among authors: lokki ml. Scand Cardiovasc J. 2009 Dec;43(6):395-401. doi: 10.1080/14017430902874305. Scand Cardiovasc J. 2009. PMID: 19365786 Clinical Trial.

8

Genetic Risk Scores Predict Recurrence of Acute Coronary Syndrome.

Vaara S, Tikkanen E, Parkkonen O, Lokki ML, Ripatti S, Perola M, Nieminen MS, Sinisalo J. Vaara S, et al. Among authors: lokki ml. Circ Cardiovasc Genet. 2016 Apr;9(2):172-8. doi: 10.1161/CIRCGENETICS.115.001271. Epub 2016 Mar 15. Circ Cardiovasc Genet. 2016. PMID: 26980882

9

Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction.

Paakkanen R, Lokki ML, Seppänen M, Tierala I, Nieminen MS, Sinisalo J. Paakkanen R, et al. Among authors: lokki ml. Atherosclerosis. 2012 Apr;221(2):461-6. doi: 10.1016/j.atherosclerosis.2012.01.024. Epub 2012 Jan 20. Atherosclerosis. 2012. PMID: 22310063

10

Clinical features of patients with homozygous complement C4A or C4B deficiency.

Liesmaa I, Paakkanen R, Järvinen A, Valtonen V, Lokki ML. Liesmaa I, et al. Among authors: lokki ml. PLoS One. 2018 Jun 21;13(6):e0199305. doi: 10.1371/journal.pone.0199305. eCollection 2018. PLoS One. 2018. PMID: 29928053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page